| Next 10 |
Ad
CLVS News and Press Clovis Oncology Inc.
News | Clovis Oncology Inc. (NASDAQ:CLVS)
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Room’s Studio / Shutterstock Clovis Oncology (NASDAQ: CLVS ) stock is on the move Monday as investors react to the pharmaceutical company filing for bankruptcy protection . The first thing that inv...
-
Clovis Oncology ( NASDAQ: CLVS ) said the company and certain subsidiaries have voluntarily started a Chapter 11 proceeding in the U.S. Bankruptcy Court for the District of Delaware and will seek to sell their assets through a court supervised sales process. In order to provi...
-
Receives Commitment for up to $75 Million in Debtor-in-Possession Financing Clovis Oncology, Inc. (NASDAQ:CLVS) (“Clovis” or the Company”), a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., E...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Jonathan Weiss / Shutterstock.com Bed Bath & Beyond (NASDAQ: BBBY ) stock has had a poor year even as the company’s stock gains today on no real news. Instead, heavy trading appears to be what h...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Top Ships (NASDAQ: TOPS ) stock is falling hard on Monday after the ocean shipping company announced the pricing of a public offering . According to a press release, that public stock offerin...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: rafapress / Shutterstock.com Investors in Clovis Oncology (NASDAQ: CLVS ) stock will want to prepare for a bankruptcy filing following a warning from the pharmaceutical company. According to a filing wit...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Once again, I drew the short (no pun intended) end of the stick and must discuss stocks to sell right now. Understandably a sensitive topic and one that arouses myriad emotions, I’m just going to stick with the hard ...
-
The FDA is asking Clovis Oncology ( NASDAQ: CLVS ) to narrow the second-line epithelial ovarian, fallopian tube, or primary peritoneal cancer indication of its treatment Rubraca (rcaparib) to tBRCA mutation patients only. The agency noted that if an agreement...
-
There’s been a brief cool-off of penny stocks under $1. One of the reasons has been the general market uncertainty thanks to mixed messages from the FOMC compared to Fed Chair Powell. A slew of economic data has also been hanging in the balance, which was seen as the catalyst...
-
Summary Shares of early clinical-stage biotech Tango Therapeutics, Inc. are down ~50% since going public in August 2021 – primarily victimized by a lack of catalysts and a tough market. However, the shares have rallied strongly over the past month. Tango Therapeutics&#x...
Stock Information
Get CLVS Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Receives Commitment for up to $75 Million in Debtor-in-Possession Financing Clovis Oncology, Inc. (NASDAQ:CLVS) (“Clovis” or the Company”), a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., E...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the development of the new next generation AABB Wallet App is nearing completion. The AABB Wallet development team, led by the Koinfold Cr...